USFDA inspections back in full swing for Pharma Companies

USFDA plant inspections seem to be coming back strongly after a two-year hiatus, going by the just-concluded inspection at Zydus Lifesciences on March 10 and a warning letter to Aurobindo earlier this year, in mid-January.

USFDA officials commented in February 2022 that USFDA is keen on restarting pharma companies inspections, including surprise inspections in India.

USFDA could be set for a busy year in India as the backlog of redressals from previous inspections and pending applications for plants and products become pressing.

Earlier, the total number of USFDA plant audits for drug quality assurance in India peaked in 2019 at 239.

Another 80 inspections were completed in January-March 2020 prior to Covid and slid to 5 inspections in 2021.

The surge in audit inspections could be periodic or could also be linked to evolving standards in manufacturing.

Related Posts

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

New Delhi: In a sweeping international crackdown, the Narcotics Control Bureau (NCB) and the US Drug Enforcement Administration (DEA) have dismantled the Indian nerve center of a massive transnational drug…

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Commissioner of Food Safety Tukaram Mundhe said inspections, consumer complaints and surveillance had repeatedly revealed violations Repeated violations of existing food safety regulations by manufacturers and sellers of health supplements…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines